2019
DOI: 10.1016/j.ygyno.2019.01.022
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of gastric-type mucinous carcinoma of the uterine cervix — An aggressive tumor with a poor prognosis: A multi-institutional study

Abstract: GAS showed aggressive behavior with ominous histopathological predictors as well as decreased survival.• GAS also showed resistance to radiotherapy.• GAS is therefore considered a distinct entity that should be distinguished from UEA. a b s t r a c tObjective. Gastric-type mucinous carcinoma (GAS) is a novel variant of mucinous carcinoma of the uterine cervix. As shown in the original Japanese group description, in recent studies, GAS represents a more aggressive disease than the usual-type endocervical adenoc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
118
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 115 publications
(136 citation statements)
references
References 27 publications
5
118
1
Order By: Relevance
“…GMC frequently metastasizes to the extrapelvic organs and exhibits worse prognosis (24). Our results are consistent with those of a recent study by Nishio et al (25) with the largest GMC cohort, which ultimately demonstrated that GMC is more significantly associated with bulky mass, deep stromal invasion, and parametrial invasion than UEA. Our observations that all GMC cases classified as FIGO stage II-IV, but the majority (80.0%) of the UEA patients had FIGO stage I tumors is in accordance with those of Karamurzin et al (24), which showed that GMC presents at more advanced stages than UEA.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…GMC frequently metastasizes to the extrapelvic organs and exhibits worse prognosis (24). Our results are consistent with those of a recent study by Nishio et al (25) with the largest GMC cohort, which ultimately demonstrated that GMC is more significantly associated with bulky mass, deep stromal invasion, and parametrial invasion than UEA. Our observations that all GMC cases classified as FIGO stage II-IV, but the majority (80.0%) of the UEA patients had FIGO stage I tumors is in accordance with those of Karamurzin et al (24), which showed that GMC presents at more advanced stages than UEA.…”
Section: Discussionsupporting
confidence: 92%
“…Our observations that all GMC cases classified as FIGO stage II-IV, but the majority (80.0%) of the UEA patients had FIGO stage I tumors is in accordance with those of Karamurzin et al (24), which showed that GMC presents at more advanced stages than UEA. Nishio et al (25) reported that lymphovascular invasion, ovarian metastasis, pelvic lymph node metastasis, and recurrence, all of which are conventional pathological features that predict worse prognosis, were more frequently observed in GMC compared to in UEA. However, a significant difference was not observed in the frequency of the lymphovascular invasion, adnexal extension, lymph node metastasis, and local recurrence between GMC and UEA.…”
Section: Discussionmentioning
confidence: 99%
“…This article is protected by copyright. All rights reserved surgical sampling specimens [1][2][3] . The reported cytologic diagnostic features of GAS are subtle and include monolayered and honeycombed sheets of cells with vacuolar or foamy cytoplasm, vesicular nuclei with distinct nucleoli, and minimal to absent mitotic activity 4,5 .…”
Section: Accepted Articlementioning
confidence: 99%
“…It may be that the outcome of patients with endocervical adenocarcinoma is closely related to the incidence of GAS, because other NHPVAs, including clear cell carcinoma, are rare. Some studies have estimated that the incidence of GAS is higher in Japan, accounting for 25–30% of all endocervical adenocarcinomas, explaining the lower rate of detection of high‐risk HPV in this country. In contrast, GAS appears to be less frequent in western countries, and a recent European study based on the updated 2014 WHO classification reported an incidence of 1.5% (7/461) .…”
Section: Paradigm Shiftmentioning
confidence: 99%